Item  2.02 Results of Operations and Financial Condition.

On October 24, 2006, Seattle Genetics, Inc. issued a press release announcing financial results for its third quarter ended September 30, 2006. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated into this Form 8-K by reference.

The information included under Item 2.02 of this report is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

  99.1 Press Release of Seattle Genetics, Inc. dated October 24, 2006

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    SEATTLE GENETICS, INC.
Date: October 24, 2006    

By:

  /s/ Clay B. Siegall
       

Clay B. Siegall

President and Chief Executive Officer

INDEX TO EXHIBITS

 

Exhibit No.   

Description

99.1    Press Release of Seattle Genetics, Inc. dated October 24, 2006